Bristol Myers braves failed Reblozyl phase 3, plans FDA talks for potential anemia expansion

fiercepharma.com/pharma/bristol-myers-braves-failed-reblozyl-ph-3-fda-filing-talks-potential-anemia-expansion

This story appeared on fiercepharma.com, 2025-07-20 08:46:47.332000.
The Entire Business World on a Single Page. Free to Use →